Xenotransplantation is inching closer to clinical reality at Columbia, where decades of work in immune tolerance are converging to make lifesaving pig-to-human organ transplants possible.
When a West Point graduate’s wife faced a rare, life-threatening cancer, it was a fellow alum—now a pioneering liver surgeon at Columbia—who stepped in to save her life.
Columbia has enrolled the first patient in a multicenter clinical trial investigating extracellular vesicle technology for the treatment of perianal fistulizing Crohn's Disease.
Columbia/NewYork-Presbyterian has once again been ranked among the nation’s best hospitals by the 2025-2026 U.S. News & World Report rankings, with top national recognition for surgical excellence across both adult and pediatric specialties.
Organ donation is not just a selfless act; it’s a rapidly evolving field shaped by science, ethics, and the quiet determination of people working to save lives in new and extraordinary ways.
Dr. Michel Sadelain, a pioneer of CAR T-cell therapy, is leading Columbia’s new initiative to expand the use of genetically engineered “living drugs” beyond cancer and into fields like autoimmunity and organ transplantation.
Looking for a heart surgeon? Learn how to find a top cardiac or cardiothoracic surgeon for valve disease, bypass, transplant, or minimally invasive surgery.
It takes an extraordinary blend of technology, trust, and teamwork to make robotic liver surgery possible for children—and Columbia’s program is leading the way.
From robotic emergency surgeries to scar-free innovations and cutting-edge critical care, Dr. Katherine Fischkoff shares how Columbia’s Division of General Surgery is rewriting what’s possible in acute and community care.
